All News #Library
Biotech
Merz Enrolls First Patients In 2 Ph3 XEOMIN Migraine Trials
25 Aug 2025 //
BUSINESSWIRE
Teijin Pharma gets approval for new Xeomin use in Japan
26 Jun 2025 //
INDPHARMAPOST

Market Place
Sourcing Support